Form 4: Surmodics Inc. Executive Charles W. Olson Reports Stock Transaction

Surmodics Inc. SVP, Medical Device Coatings, Charles W. Olson, reports the disposal of 959 shares of common stock to cover tax obligations.

Summary

• Charles W. Olson, SVP of Medical Device Coatings at Surmodics Inc., reported a transaction involving the company's common stock.
• On December 4, 2024, Mr. Olson disposed of 959 shares of common stock at a price of $39.91 per share.
• This transaction was categorized as a disposition to cover tax obligations.
• Following the transaction, Mr. Olson directly owns 51,478 shares of Surmodics common stock.
• He also indirectly owns 800 shares through an IRA.

Sentiment

Score: 5

Explanation: The document is a neutral report of a routine stock transaction by an executive. It does not indicate any positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
• The transaction is typical for executives who may sell shares to cover tax obligations related to stock-based compensation.
• Similar filings are regularly made by executives at comparable medical device companies such as Medtronic, Boston Scientific, and Abbott.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale of shares by an executive.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Surmodics, SRDX, stock transaction, insider trading, Form 4, executive, medical device coatings, common stock, tax obligations